All In Biotech

Company · BMRN

BioMarin

Includes drugs filed under related and acquired sponsor names. Trials are searched under: BioMarin Pharmaceutical.

Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov

NDAs and BLAs

8

8 still marketed

Novel approvals

7

Approvals since 2021

4

Originals and new uses

Phase 3 trials

27

Registered, any status

Trials by phase

All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.

Recent approvals

Originals and efficacy supplements, newest first.

  • Palynziq new use Priority reviewOrphanFeb 27, 2026
  • Brineura new use OrphanJul 24, 2024
  • Voxzogo new use OrphanOct 20, 2023
  • Voxzogo approved NovelAccelerated approvalOrphanNov 19, 2021
  • Palynziq new use OrphanOct 6, 2020
  • Palynziq new use OrphanOct 6, 2020
  • Palynziq new use OrphanOct 6, 2020
  • Palynziq approved NovelPriority reviewOrphanMay 24, 2018
  • Brineura approved NovelPriority reviewOrphanApr 27, 2017
  • Kuvan new use Priority reviewOrphanApr 23, 2014

Drugs in development (5)

Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.

Open in pipeline

Recruiting Phase 3 trials

Largest first.

Marketed drugs (8)

Newest FDA action first.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.